Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients

Inclusion Criteria: * Written informed consent * Ability and willingness to adhere to study regimen * Completed core study with assigned regimen; Exclusion Criteria: Patients fulfilling any of the following criteria are not eligible for inclusion in this study: * Severe hypercholesterolemia or hypertriglyceridemia. * Low platelet count. * Low white blood cell count. * Positive test for human immunodeficiency virus (HIV). * Systemic infection requiring active use of IV antibiotics. * Patients in a critical care setting. * Use of prohibited medication. * Use of immunosuppressive agents not utilized in the protocol. * Hypersensitivity to any of the study drugs or similar drugs. * Pregnant or nursing (lactating) women * Women of child-bearing potential not using a highly effective method of birth control. Other protocol-defined inclusion/exclusion criteria may apply